论文部分内容阅读
目的探讨终末期糖尿病肾病腹膜透析治疗的临床效果。方法 80例终末期糖尿病肾病患者,随机分为对照组和观察组,各40例。对照组实施血液透析治疗,观察组采用腹摸透析治疗。对比两组临床效果。结果对照组治疗后的收缩压为(157.52±23.38)mm Hg(1 mm Hg=0.133 k Pa)、舒张压为(98.78±11.56)mm Hg、甘油三脂为(1.65±0.46)mmol/L、总胆固醇为(4.78±1.02)mmol/L。观察组治疗后的收缩压为(141.38±20.06)mm Hg、舒张压为(80.78±9.56)mm Hg、甘油三脂为(3.46±0.82)mmol/L、总胆固醇为(7.89±1.39)mmol/L。观察组均优于对照组(P<0.05)。结论采取腹膜透析治疗终末期糖尿病肾病患者的疗效显著,值得在临床上推广。
Objective To investigate the clinical effect of peritoneal dialysis for end-stage diabetic nephropathy. Methods Eighty patients with end stage diabetic nephropathy were randomly divided into control group and observation group, 40 cases in each. Control group hemodialysis treatment, observation group using abdominal touch dialysis treatment. Compare the clinical effect of two groups. Results The systolic blood pressure of the control group after treatment was (157.52 ± 23.38) mm Hg (1 mm Hg = 0.133 kPa), diastolic pressure was (98.78 ± 11.56) mm Hg and triglyceride was (1.65 ± 0.46) mmol / Total cholesterol was (4.78 ± 1.02) mmol / L. After treatment, the systolic blood pressure and the total cholesterol in the observation group were (141.38 ± 20.06) mm Hg, (80.78 ± 9.56) mm Hg, (3.46 ± 0.82) mmol / L, and 7.89 ± 1.39 mmol / L. The observation group were better than the control group (P <0.05). Conclusion Peritoneal dialysis treatment of patients with end-stage diabetic nephropathy significant effect, it is worth in the clinical promotion.